• AAPL 181.71
  • TSLA 184.76
  • AMZN 188.7
  • MSFT 413.54
  • INTC 30.97
  • EURUSD 1.0774
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. PA /
  3. ALNOV.PA

Novacyt (ALNOV PA) stock market data APIs

€0.342 -0.43(-55.8%) as of May 6, 2024

Novacyt Financial Data Overview

0.331
0.342
-
0.756
0.372
0.42-0.995
58 658 K
70 626 K
7 871 K
-1.708
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'ALNOV',
Type: 'Common Stock',
Name: 'Novacyt',
Exchange: 'PA',
CurrencyCode: 'EUR',
CurrencyName: 'Euro',
CurrencySymbol: '€',
CountryName: 'France',
CountryISO: 'FR',
OpenFigi: NULL,
ISIN: 'FR0010397232',
CIK: NULL,
EmployerIdNumber: '',
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: 'International',
Sector: 'Healthcare',
Industry: 'Medical Devices',
}

Novacyt Fundamental Data is available in our Financial Data APIs

  • Net Revenue 7 871 K
  • EBITDA -13 673 000
  • Earnings Per Share -0.4
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Novacyt Earnings via APIs

  • Latest Release 2024-04-25
  • EPS/Forecast NaN

Get Novacyt End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Novacyt latest news via APIs

Novacyt S.A. ("Novacyt", the "Company" or the "Group"): DHSC Claim Update – Trial Date Listed

PARIS & EASTLEIGH, England, January 30, 2023--(BUSINESS WIRE)--Regulatory News: Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that the Hi...
  • BUSINESS WIRE
  • CLINICAL DIAGNOSTICS
  • CORPORATE FINANCE
  • HIGH COURT
  • INTERNATIONAL DIAGNOSTICS
  • INTERNATIONAL SPECIALIST
  • NOVACYT
  • NOVACYT GROUP
  • REGULATORY NEWS

Novacyt S.A. ("Novacyt", the "Company" or the "Group") Full Year 2022 Trading Update

Full year revenue and EBITDA in line with guidance Remain focused on post-COVID-19 growth strategy to become a leading global clinical diagnostics company in infectious diseases PARIS & EASTLEIGH, E...
  • CLINICAL DIAGNOSTICS
  • COMPANY
  • DIAGNOSTIC PORTFOLIO
  • GROUP REVENUE
  • INFECTIOUS DISEASE
  • NOVACYT
  • NOVACYT GROUP
  • THE COMPANY
Do you have any questions?
support@eodhistoricaldata.com